ACCP Commentary
Strategies for Developing Pharmacy Residents as Educators
Daniel S. Aistrope, Pharm.D., Russell T. Attridge, Pharm.D., M.Sc., Aida R. Bickley, Pharm.D., Matthew R. Browne, Pharm.D., Ashley D. Hall, Pharm.D., Abigail E. Miller, Pharm.D., Megan E. Sheahan, Pharm.D., Emma M. Tillman, Pharm.D., and Katy E. Trinkley, Pharm.D.
Case Reports
Therapeutic Drug Monitoring in Patients Coinfected with Human Immunodeficiency Virus and Disseminated Mycobacterium avium Complex
Keith J. Dunn, Pharm.D., Paul R. Skolnik, M.D., Leyla Azis, M.D., and Helene Hardy, Pharm.D.
Pharmacokinetics of the Long-Acting, First-Generation Antipsychotic Fluphenazine
Tara L. Purvis, Pharm.D., Robin N. Hieber, Pharm.D., Timothy Dellenbaugh, M.D., and Roger W. Sommi, Pharm.D., FCCP
Levetiracetam-Induced Acute Generalized Exanthematous Pustulosis
Said M. Sultan, Pharm.D., and Lindsay M. Daniels, Pharm.D.
Alternative Viewpoints
Stover KR, Cleary JD. Use of Echinocandins for Candida parapsilosis Infections
commenting on Kale-Pradhan PB, Morgan G, Wilhelm SM, Johnson LB. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a metaanalysis. Pharmacotherapy 2010;30(12):1207–13.